Reprogramming Human Embryonic Stem Cells with Drugs
Author Information
Author(s): Azghadi Soheila MD, Clark Amander T. PhD
Primary Institution: University of California Los Angeles
Hypothesis
Can 3-deazaneplanocin A and sodium butyrate effectively reprogram Class II and Class III human embryonic stem cell lines to a Class I state?
Conclusion
The study demonstrated that the combination of DZNep and sodium butyrate can lead to the reprogramming of certain human embryonic stem cell lines to a more naive state.
Supporting Evidence
- Three Class II hESC lines were used in the study.
- DZNep was shown to selectively inhibit H3K27me3, a repressive chromatin mark.
- Sodium butyrate was used to enhance self-renewal and up-regulate germ cell specific markers.
Takeaway
Scientists used two drugs to help special cells called stem cells become more like their original state, which could help in medical research.
Methodology
The study involved culturing human embryonic stem cells and treating them with DZNep and sodium butyrate to observe changes in their epigenetic state.
Limitations
The study primarily focused on a limited number of cell lines and did not explore the long-term effects of the treatments.
Want to read the original?
Access the complete publication on the publisher's website